Related references
Note: Only part of the references are listed.Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms
Min Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis, and osmotic protection
Elizabeth Reyna-Beltran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The external face of Candida albicans: A proteomic view of the cell surface and the extracellular environment
Ana Gil-Bona et al.
JOURNAL OF PROTEOMICS (2018)
New CRISPR Mutagenesis Strategies Reveal Variation in Repair Mechanisms among Fungi
Valmik K. Vyas et al.
MSPHERE (2018)
Microbe Profile: Candida albicans: a shape-changing, opportunistic pathogenic fungus of humans
Neil A. R. Gow et al.
MICROBIOLOGY-SGM (2017)
ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes
Haaglim Cho et al.
SCIENTIFIC REPORTS (2017)
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats
Mahasen A. Radwan et al.
DRUG DELIVERY (2017)
Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans
De-Dong Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Activity of Sanguinarine against Candida albicans Biofilms
Hua Zhong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro
Bo Ma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013
R. Rajendran et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Is there an emerging need for new antifungals?
John R. Perfect
EXPERT OPINION ON EMERGING DRUGS (2016)
Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery
Qingxiang Song et al.
MOLECULAR PHARMACEUTICS (2016)
Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model
Shaunna L. Beedie et al.
SCIENTIFIC REPORTS (2016)
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase
Nikunj Satani et al.
PLOS ONE (2016)
Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole
Li Ping Li et al.
PLOS ONE (2015)
Candida species epidemiology 2000-2013: a laboratory-based report
Kee Peng Ng et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
Candida albicans Shaving to Profile Human Serum Proteins on Hyphal Surface
Elvira Marin et al.
FRONTIERS IN MICROBIOLOGY (2015)
In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
Semanti Sarkar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Time-Kill Assay and Etest Evaluation for Synergy with Polymyxin B and Fluconazole against Candida glabrata
George Pankey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antifungal drug discovery: the process and outcomes
Richard Calderone et al.
FUTURE MICROBIOLOGY (2014)
Serum Antibody Signature Directed against Candida albicans Hsp90 and Enolase Detects Invasive Candidiasis in Non-Neutropenic Patients
Aida Pitarch et al.
JOURNAL OF PROTEOME RESEARCH (2014)
A Unique Small Molecule Inhibitor of Enolase Clarifies Its Role in Fundamental Biological Processes
Da-Woon Jung et al.
ACS CHEMICAL BIOLOGY (2013)
Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence
Hui-Ching Ko et al.
JOURNAL OF MICROBIOLOGY (2013)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The NDR/LATS Kinase Cbk1 Controls the Activity of the Transcriptional Regulator Bcr1 during Biofilm Formation in Candida albicans
Pilar Gutierrez-Escribano et al.
PLOS PATHOGENS (2012)
Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases
Selma Tobudic et al.
MYCOSES (2010)
Our Current Understanding of Fungal Biofilms
Gordon Ramage et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2009)
Role of the RAM Network in Cell Polarity and Hyphal Morphogenesis in Candida albicans
Yunkyoung Song et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Mutations on CaENO1 in Candida albicans inhibit cell growth in the presence of glucose
YL Yang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
H Quan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods
E Cantón et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule
G Ramage et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
Resistance mechanisms in clinical isolates of Candida albicans
TC White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Transglutaminase activity is involved in Saccharomyces cerevisiae wall construction
M Iranzo et al.
MICROBIOLOGY-SGM (2002)
Conserved serine/threonine kinase encoded by CBK1 regulates expression of several hypha-associated transcripts and genes encoding cell wall proteins in Candida albicans
MD McNemar et al.
JOURNAL OF BACTERIOLOGY (2002)
In vitro low-level resistance to Azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry
A Kohli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
G Ramage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Influence of human serum on antifungal pharmacodynamics with Candida albicans
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
